$YOLO

The Motley Fool·Apr 24Neutral

Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?

The Justice Department reclassified state-licensed marijuana from Schedule I to Schedule III, with a June hearing planned for recreational marijuana reclassification. This follows President Trump's executive order to downgrade cannabis to a less restrictive category. The move could ease the cannabis industry's banking access and tax burden issues, potentially increasing demand and state legalization efforts.

The Motley Fool·Oct 1Bullish

1 Major Reason Cannabis Stocks Surged This Week

Marijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.

Benzinga·Oct 9Bullish

EXCLUSIVE: 'Poking The Bear' As Florida's Contentious Cannabis Legalization Vote Looms

Florida's cannabis legalization campaign for Amendment 3 has been record-breaking, raising over $100 million. However, the campaign has faced lawsuits from Trulieve and a state senator, which the panelists view as a PR strategy to discredit false narratives.

Benzinga·Sep 5Bullish

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Former President Donald Trump's recent comments supporting cannabis legalization in Florida have sparked optimism in the cannabis market, leading to varied reactions among cannabis stocks.

Benzinga·May 21

Cannabis Stocks And ETFs Surged On Marijuana Rescheduling News: WTR's Industry Report Analyzes What's Behind The Optimism

The Department of Justice (DOJ) move to reclassifying cannabis from Schedule I to Schedule III provoked a noticeable uptick in cannabis market activities, as detailed in the latest industry report by Water Tower Research (WTR). Cannabis ETFs Surge Ahead Of Rescheduling Announcement According to WTR's report, the U.S. cannabis AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) rose by 2.89% last week, following $13.3 million in inflows, a spike that notably preceded the DOJ’s announcement. The global AdvisorShares Pure Cannabis ETF (NYSE:YOLO) also saw gains, climbing 3.77%. The proposed policy change, aimed at acknowledging the lesser potential for abuse compared to other controlled substances, has initiated a 60-day comment period, setting the stage for final rule enactment before the Democratic National Convention on August 19. Stay ahead in the cannabis industry’s news and views by joining industry leaders and experts at the upcoming Benzinga Cannabis Capital Conference in Chicago ...Full story available on Benzinga.com

Zacks Investment Research·Mar 22

Is Rescheduling a Certainty for Cannabis? ETFs That Surge

In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana. President Biden also lately talked about ongoing efforts to review the federal classification of marijuana, hinting at his commitment to potential reforms

Investing.com·Feb 22

Cannabis Stocks: Here's How to Maximize Your Gains Amid Sector's Strong Resurgence

Zacks Investment Research·Jan 31

Cannabis ETFs Outperform in January

The cannabis industry has been performing well this year after the US Drug Enforcement Administration started reviewing the potential reclassification of cannabis from Schedule I to Schedule III.